Fiserv, Inc.

Fundamentals6.0
Price Action4.0
News Sentiment5.0
AI Rating
5.0

Key Drivers

  • Cash Generation
  • Debt Load
  • Liquidity Thin

AI
AI Summary

5.0

Fiserv is no longer a simple payments compounder but a prove-it turnaround story: with Q1 organic revenue down 4%, margins compressing, and leverage still high, investors should wait for clear reacceleration and margin recovery before expecting a rerating, even though strong free cash flow and a ~9.5x earnings multiple leave upside if execution improves.

Turnaround‍
CashFlow
ExecutionRisk

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Cash Generation
  • Debt Load
  • Liquidity Thin

FISV remains a cash-generative but heavily leveraged business, with strong profitability and free cash flow offset by thin liquidity, high debt, and an intangible-heavy balance sheet risk.

CashFlow
Leverage

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Low-$52 support
  • Mid-$50s resistance

FISV remains in a clear last month downtrend with lower highs and lower lows, though its rebound off $52.37 and three straight gains suggest near-term support is holding and a reclaim of $56.8–$57.3 is needed to confirm a real recovery.

downtrend
support
Support Level: $52.37
Resistance Level: $56.80-$57.30

Bounced off $52.37 and recovered for three straight sessions after breaking below the mid-$50s

Sentiment & News

5.0

Key News Insights:

  • EPS Beat
  • Revenue Decline
  • Guidance Reaffirmed

Fiserv beat Q1 EPS but faced falling revenue, margin pressure, and mixed investor sentiment while reaffirming 2026 guidance and long-term plans.

Fiserv
Earnings

The stock may stay volatile as near-term operating weakness weighs on results, but reaffirmed guidance and institutional buying could support the long-term case